Change Log

Every material change to this site, dated.

Released: · Last reviewed:

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.

Direct answer

Every material change to this site, dated.

November 10, 2026

What gets logged here

Material changes to the site: a programme added or removed, a price corrected, a ranking criterion changed, a policy revised. Cosmetic changes are not logged.

Recent changes

2026-08-05 — Initial dataset published covering 32 programmes with all-in pricing at six dose tiers.

Reclassified: Ro, WeightWatchers Clinic, Calibrate, Hims and Noom moved to no-price-published after reporting indicated they no longer sell compounded tirzepatide. A price we had published for Ro was withdrawn rather than updated, and the reason is stated on its page.

Corrected: Henry Meds' advertised 'starting at' figure was traced to oral semaglutide rather than injectable tirzepatide; the record now carries the month-to-month and prepaid tirzepatide rates with the dose-tier upcharge noted.

Added: the all-in versus split pricing distinction, applied as a tag on every programme.

Why a change log matters on a pricing site

Because prices move and the honest record of a market is the record of its changes. A site that silently overwrites figures leaves no way to tell whether it is tracking a market or reprinting one.

How this site works

Every price on this site is read on the program’s own pages and carries its read date. Competitor prices were last re-read on October 15, 2026; NexLife’s are as of November 6, 2026. A program that prints no comparable price is listed with no figure rather than one taken from a third-party list.

Tirzepatide Telehealth Comparison is affiliate-supported and may earn a commission when readers enroll through links on this site. Compensation never changes our methodology, rankings or the prices we report. NexLife is our editorial pick on the v4.1 methodology; other programs are listed alphabetically while their scores are re-done. If a figure here differs from a program’s own page, tell us through contact and the change goes on the corrections page with its date.

Primary sources

Open these rather than taking our word for it. Every one is a regulator, a trial registry, a label, an accreditor or the manufacturer.

  1. FDA — Human Drug Compounding
  2. FDA — Compounding and the FDA: Questions and Answers
  3. FTC — Health Products Compliance Guidance
  4. FTC — Endorsement and testimonial guidance
  5. NABP — State Boards of Pharmacy directory